...
首页> 外文期刊>Cancer Cell International >Establishment and evaluation of four different types of patient-derived xenograft models
【24h】

Establishment and evaluation of four different types of patient-derived xenograft models

机译:四种不同类型的患者异种移植模型的建立和评估

获取原文
           

摘要

Patient-derived xenografts (PDX) have a biologically stable in tumor architecture, drug responsiveness, mutational status and global gene-expression patterns. Numerous PDX models have been established to date, however their thorough characterization regarding the tumor formation and rates of tumor growth in the established models remains a challenging task. Our study aimed to provide more detailed information for establishing the PDX models successfully and effectively. We transplanted four different types of solid tumors from 108 Chinese patients, including 21 glioblastoma (GBM), 11 lung cancers (LC), 54 gastric cancers (GC) and 21 colorectal cancers (CRC), and took tumor tissues passaged for three successive generations. Here we report the rate of tumor formation, tumor-forming times, tumor growth curves and mortality of mice in PDX model. We also report H&E staining and immunohistochemistry for HLA-A, CD45, Ki67, GFAP, and CEA protein expression between patient cancer tissues and PDX models. Tumor formation rate increased?significantly in subsequent tumor generations. Also, the survival rates of GC and CRC were remarkably higher than GBM and LC. As for the time required for the formation of tumors, which reflects the tumor growth rate, indicated that tumor growth rate always increased as the generation number increased. The tumor growth curves also illustrate this law. Similarly, the survival rate of PDX mice gradually improved with the increased generation number in GC and CRC. And generally, there was more proliferation (Ki67+) in the PDX models than in the patient tumors, which was in accordance with the results of tumor growth rate. The histological findings confirm similar histological architecture and degrees of differentiation between patient cancer tissues and PDX models with statistical analysis by GraphPad Prism 5.0. We established four different types of PDX models successfully, and our results add to the current understanding of the establishment of PDX models and may contribute to the extension of application of different types of PDX models.
机译:患者源异种移植物(PDX)在肿瘤结构,药物反应性,突变状态和整体基因表达模式方面具有生物学上的稳定性。迄今为止,已经建立了许多PDX模型,但是在已建立的模型中对其肿瘤形成和肿瘤生长速率进行全面的表征仍然是一项艰巨的任务。我们的研究旨在为成功,有效地建立PDX模型提供更详细的信息。我们从108位中国患者中移植了四种不同类型的实体瘤,包括21例胶质母细胞瘤(GBM),11例肺癌(LC),54例胃癌(GC)和21例结直肠癌(CRC),并连续三代传代了肿瘤组织。在这里,我们报告了P​​DX模型中小鼠的肿瘤形成率,肿瘤形成时间,肿瘤生长曲线和小鼠死亡率。我们还报告了H&E染色和免疫组织化学的患者癌症组织和PDX模型之间的HLA-A,CD45,Ki67,GFAP和CEA蛋白表达。在随后的肿瘤世代中,肿瘤形成率显着增加。此外,GC和CRC的生存率显着高于GBM和LC。至于肿瘤形成所需的时间,它反映了肿瘤的生长速度,表明肿瘤的生长速度总是随着世代数的增加而增加。肿瘤生长曲线也说明了这一规律。同样,PDX小鼠的存活率随着GC和CRC中代数的增加而逐渐提高。通常,PDX模型中的增殖(Ki67 +)比患者肿瘤中的更多,这与肿瘤生长速度的结果一致。组织学发现通过GraphPad Prism 5.0的统计分析证实了相似的组织学结构和患者癌症组织与PDX模型之间的分化程度。我们成功建立了四种不同类型的PDX模型,我们的结果加深​​了对PDX模型建立的当前了解,并可能有助于扩展不同类型PDX模型的应用。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号